BCAS1 Antikörper (AA 532-550)

Produktnummer ABIN1732242

Dieser Anti-BCAS1-Antikörper ist ein Kaninchen-Polyklonal-Antikörper zum Nachweis von BCAS1 in WB und IHC. Geeignet für Human.

Kurzübersicht für BCAS1 Antikörper (AA 532-550) (ABIN1732242)

Target: BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser BCAS1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Produktdetails anti-BCAS1 Antikörper

Bindungsspezifität: AA 532-550

Spezifität: Reacts with human BCAS1.

Aufreinigung: Purified

Immunogen: Synthetic peptide corresponding to amino acids 532-550 of human BCAS1/NABC1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
WB(1 - 5 μg/mL)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: PBS, pH 7.4

Handhabung: Dilute in PBS or medium that is identical to that used in the assay system.

Lagerung: -20 °C

Informationen zur Lagerung: Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu BCAS1

Target: BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))

Andere Bezeichnung: BCAS1 / NABC1

Hintergrund: Breast Carcinoma Amplified Sequence 1 (BCAS1), also known as Novel Amplified in Breast Cancer 1 (NABC1) was isolated from a region at 20q13 and is amplified in several tumor types. It is associated with more aggressive tumor phenotypes. BCAS1/NABC1 is highly expressed in some, but not all, breast cancer cell lines and in some breast tumors at 20q13.2. The BCAS1/NABC1 gene is predicted to encode a protein of 584 amino acids with no significant homology to other proteins.

Breast carcinoma-amplified sequence 1 Amplified and overexpressed in breast cancer Novel amplified in breast cancer 1 Gene name: BCAS1, AIBC1, NABC1

Gen-ID: 8537

UniProt: O75363